Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) - Total Liabilities

Latest as of March 2026: CN¥3.31 Billion CNY ≈ $483.97 Million USD

Based on the latest financial reports, Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has total liabilities worth CN¥3.31 Billion CNY (≈ $483.97 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 301408 financial resilience to evaluate the company's liquid asset resilience ratio.

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A - Total Liabilities Trend (2021–2025)

This chart illustrates how Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Anhui Huaren Health Pharmaceutical Co. L's balance sheet.

Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Competitors by Total Liabilities

The table below lists competitors of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A ranked by their total liabilities.

Company	Country	Total Liabilities
S.J.S. Enterprises Limited NSE:SJS	India	Rs-8.81 Billion
Johns LYNG Group Ltd AU:JLG	Australia	AU$524.22 Million
Zhejiang Truelove Vogue Co Ltd SHE:003041	China	CN¥874.66 Million
Logwin AG F:TGHN	Germany	€394.61 Million
Lincoln Educational Services NASDAQ:LINC	USA	$293.48 Million
Standard Foods Corp TW:1227	Taiwan	NT$7.70 Billion
Fujian Nanping Sun Cable Co Ltd SHE:002300	China	CN¥4.27 Billion
Wuhan Zhongyuan Huadian Sci Tech SHE:300018	China	CN¥275.13 Million

Liability Composition Analysis (2021–2025)

This chart breaks down Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 301408 equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.13	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.52	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)

The table below shows the annual total liabilities of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥3.33 Billion ≈ $486.59 Million	+20.15%
2024-12-31	CN¥2.77 Billion ≈ $405.00 Million	+5.03%
2023-12-31	CN¥2.64 Billion ≈ $385.61 Million	+61.75%
2022-12-31	CN¥1.63 Billion ≈ $238.40 Million	+37.37%
2021-12-31	CN¥1.19 Billion ≈ $173.55 Million	--

About Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A

SHE:301408 China Pharmaceutical Retailers

Market Cap

$806.01 Million

CN¥5.51 Billion CNY

Market Cap Rank

#9872 Global

#2545 in China

Share Price

CN¥13.77

Change (1 day)

-1.36%

52-Week Range

CN¥12.60 - CN¥29.76

All Time High

CN¥29.76